HBP1 and breast carcinoma: EGCG induced HMG-box transcription factor 1 (HBP1) transcriptional repressor, resulting in blockage of the Wnt/β-catenin pathway and inhibition of both breast cancer cell tumorigenic proliferation and invasiveness [33].